SEC EDGAR CompanyFacts fact · reporting period
PHARMACYTE BIOTECH, INC.: operating_income
One fact, its scope and the complete path back to the official record.
Reported value
$-13.261M{"amount": -13260735, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}- Entity
- PHARMACYTE BIOTECH, INC.
- Metric
- operating_income
- Period
- 2014-05-01 – 2015-04-30
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-08-19T11:33:33.623054+02:00
Raw response SHA-256
f7bde1a401b286c74a2fd824ee1df541…Official-identifier path
https://factanker.com/fact/sec/cik-0001157075/operating-income/2015-04-30 (CIK, metric, reporting date)History
- supersedes {"amount": -13695489, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001019687-15-002894)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.